Martin Auster
Stock Analyst at Raymond James
(4.53)
# 1,069
Out of 5,144 analysts
210
Total ratings
49.5%
Success rate
13.2%
Average return
Main Sectors:
Stocks Rated by Martin Auster
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Maintained: Buy | $37 → $41 | $17.99 | +127.90% | 7 | Nov 12, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $66 → $85 | $47.57 | +78.68% | 5 | Nov 5, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $420 → $315 | $159.85 | +97.06% | 6 | Oct 30, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $271 → $287 | $259.28 | +10.69% | 2 | Sep 15, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $60 → $72 | $46.60 | +54.51% | 6 | Sep 14, 2026 | |
| EVMN Evommune | Reiterated: Buy | $40 → $18 | $8.62 | +108.82% | 3 | Sep 9, 2026 | |
| STTK Shattuck Labs | Initiated Coverage: Buy | $18 | $5.05 | +256.44% | 1 | Aug 24, 2026 | |
| SEPN Septerna | Rated: Buy | $53 → $49 | $48.56 | +0.91% | 3 | Aug 11, 2026 | |
| PHAT Phathom Pharmaceuticals | Reiterated: Buy | $28 → $21 | $6.28 | +234.39% | 2 | Jul 31, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $5 | $0.8242 | +506.65% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.42 | +392.96% | 2 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $79.54 | - | 4 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $81 | $21.96 | +268.85% | 2 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $106.82 | -25.11% | 1 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $56 | $36.73 | +52.46% | 2 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $108 → $117 | $87.08 | +34.36% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $3.42 | +660.23% | 4 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $58.53 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $6 | $46.20 | n/a | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 → $100 | $58.33 | n/a | 14 | Oct 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $3.74 | n/a | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $12 | $23.25 | n/a | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $8 | $7.60 | n/a | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 → $58 | $27.76 | n/a | 6 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $156 → $72 | $16.68 | n/a | 23 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $169 → $196 | $595.66 | n/a | 17 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $98 | $1.12 | n/a | 5 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $99 | $16.70 | n/a | 15 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $60 | $120.75 | n/a | 17 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $54 | $64.91 | n/a | 12 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $78 | $24.59 | n/a | 5 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $12 | $4.87 | n/a | 9 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $11.41 | n/a | 4 | Nov 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $43 | $7.73 | n/a | 4 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $484.00 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $48.77 | n/a | 8 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $16 → $4 | $0.0001 | n/a | 3 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $1.02 | n/a | 1 | Jan 18, 2018 |
Dyne Therapeutics
Nov 12, 2026
Maintained: Buy
Price Target: $37 → $41
Current: $17.99
Upside: +127.90%
Edgewise Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $66 → $85
Current: $47.57
Upside: +78.68%
Alnylam Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $420 → $315
Current: $159.85
Upside: +97.06%
Ascendis Pharma
Sep 15, 2026
Reiterated: Buy
Price Target: $271 → $287
Current: $259.28
Upside: +10.69%
Scholar Rock Holding
Sep 14, 2026
Reiterated: Buy
Price Target: $60 → $72
Current: $46.60
Upside: +54.51%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $40 → $18
Current: $8.62
Upside: +108.82%
Shattuck Labs
Aug 24, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $5.05
Upside: +256.44%
Septerna
Aug 11, 2026
Rated: Buy
Price Target: $53 → $49
Current: $48.56
Upside: +0.91%
Phathom Pharmaceuticals
Jul 31, 2026
Reiterated: Buy
Price Target: $28 → $21
Current: $6.28
Upside: +234.39%
iBio, Inc.
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.8242
Upside: +506.65%
May 28, 2026
Reiterated: Buy
Price Target: $6 → $7
Current: $1.42
Upside: +392.96%
May 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $79.54
Upside: -
May 26, 2026
Reiterated: Buy
Price Target: $76 → $81
Current: $21.96
Upside: +268.85%
Apr 10, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $106.82
Upside: -25.11%
Mar 25, 2026
Reiterated: Buy
Price Target: $48 → $56
Current: $36.73
Upside: +52.46%
Jan 13, 2026
Reiterated: Buy
Price Target: $108 → $117
Current: $87.08
Upside: +34.36%
Jan 13, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $3.42
Upside: +660.23%
Jul 30, 2025
Downgraded: Hold
Price Target: n/a
Current: $58.53
Upside: n/a
Nov 16, 2021
Reiterated: Buy
Price Target: $26 → $6
Current: $46.20
Upside: n/a
Oct 28, 2021
Reiterated: Buy
Price Target: $102 → $100
Current: $58.33
Upside: n/a
Mar 22, 2021
Initiated Coverage: Buy
Price Target: $26
Current: $3.74
Upside: n/a
Mar 16, 2021
Reiterated: Buy
Price Target: $29 → $12
Current: $23.25
Upside: n/a
Mar 16, 2021
Reiterated: Hold
Price Target: $7 → $8
Current: $7.60
Upside: n/a
Mar 10, 2021
Reiterated: Buy
Price Target: $49 → $58
Current: $27.76
Upside: n/a
Mar 2, 2021
Reiterated: Hold
Price Target: $156 → $72
Current: $16.68
Upside: n/a
Feb 22, 2021
Reiterated: Buy
Price Target: $169 → $196
Current: $595.66
Upside: n/a
Feb 11, 2021
Reiterated: Buy
Price Target: $62 → $98
Current: $1.12
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $64 → $99
Current: $16.70
Upside: n/a
Jan 19, 2021
Reiterated: Buy
Price Target: $50 → $60
Current: $120.75
Upside: n/a
Jan 11, 2021
Reiterated: Hold
Price Target: $53 → $54
Current: $64.91
Upside: n/a
Nov 20, 2020
Reiterated: Buy
Price Target: $76 → $78
Current: $24.59
Upside: n/a
Nov 6, 2020
Reiterated: Hold
Price Target: $11 → $12
Current: $4.87
Upside: n/a
Nov 5, 2020
Reiterated: Hold
Price Target: $21 → $24
Current: $11.41
Upside: n/a
Oct 8, 2020
Reiterated: Buy
Price Target: $27 → $43
Current: $7.73
Upside: n/a
Sep 23, 2020
Reiterated: Buy
Price Target: n/a
Current: $484.00
Upside: n/a
Jul 7, 2020
Reiterated: Hold
Price Target: $16
Current: $48.77
Upside: n/a
Nov 7, 2019
Downgraded: Hold
Price Target: $16 → $4
Current: $0.0001
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $1.02
Upside: n/a